Prosecution Insights
Last updated: April 19, 2026

Sutro Biopharma, Inc.

9 pending office actions

Portfolio Summary

9
Total Pending OAs
4
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18638420 ANTI-BCMA ANTIBODIES AND TREATMENT METHODS KAUFMAN, CLAIRE M 1674 Final Rejection Apr 17, 2024
18231204 SPRAY DRIED EXTRACT REGLAS, GEORGIANA C 1651 Non-Final OA Aug 07, 2023
18357966 ANTIBODIES WITH ENGINEERED CH2 DOMAINS, COMPOSITIONS THEREOF AND METHODS OF USING THE SAME LU, CHENG 1642 Final Rejection Jul 24, 2023
18203348 IMMUNOMODULATOR ANTIBODY DRUG CONJUGATES AND USES THEREOF HELLMAN, KRISTINA M 1654 Final Rejection May 30, 2023
17908882 ANTIBODIES COMPRISING SITE-SPECIFIC GLUTAMINE TAGS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE HUYNH, PHUONG N 1641 Final Rejection Sep 01, 2022
17727395 ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE HUYNH, PHUONG N 1641 Non-Final OA Apr 22, 2022
17276757 COMBINATION THERAPIES WITH ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES ESSEX, LAURA ANN 1675 Non-Final OA Mar 16, 2021
16991607 EXPRESSION OF BIOLOGICALLY ACTIVE PROTEINS IN A BACTERIAL CELL-FREE SYNTHESIS SYSTEM USING BACTERIAL CELLS TRANSFORMED TO EXHIBIT ELEVATED LEVELS OF CHAPERONE EXPRESSION RYAN, DOUGLAS CHARLES 1635 Non-Final OA Aug 12, 2020
16395649 HIGH GROWTH CAPACITY AUXOTROPHIC ESCHERICHIA COLI AND METHODS OF USE PERSONS, JENNA L 1637 Non-Final OA Apr 26, 2019

Managing Sutro Biopharma, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month